ITRE reaches agreement on FP7

The European Parliament's Industry, Research and Energy Committee (ITRE) has adopted, in a second reading, a set of comprise amendments on the Seventh Framework Programme (FP7), which were agreed upon in informal meetings with the Council.

The 39 new amendments deal with issues such as the structure of the European Research Council (ERC) and the proposed Risk Sharing Finance Facility (RSFF).

MEPs agreed on an amendment on renewable and end use energy, which foresees a 'major part' of the budget from FP7's energy theme going to the field, instead of two thirds as proposed by the Parliament in its first reading. According to ITRE, special attention will be devoted to the coordination of issues linked to rational and efficient use of energy in FP7 and in other EU policies.

A compromise was also reached regarding the administrative costs of the ERC, which should now not exceed 5% - MEPs had originally asked for a limit of 3%. On the issue of the Parliament's involvement in the interim evaluation of the ERC, it was agreed to opt for co-decision procedure in case changes in the structure of ERC become necessary.

ITRE also endorsed amendments on the rules of participation for companies, research centres and universities, as well as the RSFF, which is designed to encourage bank lending to research projects. Initially, the Council had planned to allocate €1 billion from the FP7 budget to finance RSFF. However, under the amendment, a lower contribution of €500 million is foreseen until 2010, with the possibility of releasing the additional €500 million after a review.

On the European Institute of Technology (EIT), the committee stressed that no money from FP7 should be used to finance the proposed structure. Only administrative costs directly associated with research projects may be covered.

The amended text will be put to the vote at a Parliament plenary session, due to be held on 29 November, before it is put to the Council on 5 December.

If all goes to plan, the first calls for proposals for FP7 projects could be published by December 2006, with closing dates in March 2007. Following an evaluation period, the first FP7 projects could start as early as the end of 2007 or early 2008

For further information on FP7, please visit:
http://cordis.europa.eu/fp7/

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Leveraging AI to Assist Clinicians with …

Physical examinations are important diagnostic tools that can reveal critical insights into a patient's health, but complex conditions may be overlooked if a clinician lacks specialized training in that area...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

New AI Tool Uses Routine Blood Tests to …

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of...

Using AI to Uncover Hospital Patients�…

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may...

New Method Tracks the 'Learning Cur…

Introducing Annotatability - a powerful new framework to address a major challenge in biological research by examining how artificial neural networks learn to label genomic data. Genomic datasets often contain...